J. Lipid Res. Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M700293-JLR200 on January 7, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M700293-JLR200v1
49/4/763    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishizawa, M.
Right arrow Articles by Makishima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishizawa, M.
Right arrow Articles by Makishima, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 763-772, April 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia

Michiyasu Ishizawa*,{dagger}, Manabu Matsunawa*,§, Ryutaro Adachi**, Shigeyuki Uno*, Kazumasa Ikeda{dagger}, Hiroyuki Masuno{dagger}{dagger}, Masato Shimizu§§, Ken-ichi Iwasaki***, Sachiko Yamada* and Makoto Makishima1,*

* Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan
§ Open Research Center for Genome and Infectious Disease Control, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan
*** Division of Hygiene, Department of Social Medicine, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan
{dagger} Department of Applied Biological Science, Nihon University College of Bioresource Sciences, Fujisawa, Kanagawa 252-8510, Japan
** Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan
{dagger}{dagger} Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo 101-0062, Japan
§§ School of Biomedical Science, Tokyo Medical and Dental University, Chiyoda-ku, Tokyo 101-0062, Japan

Published, JLR Papers in Press, January 7, 2008.

1 To whom correspondence should be addressed. e-mail: maxima{at}med.nihon-u.ac.jp

1{alpha},25-Dihydroxyvitamin D3 [1,25(OH)2D3], a vitamin D receptor (VDR) ligand, regulates calcium homeostasis and also exhibits noncalcemic actions on immunity and cell differentiation. In addition to disorders of bone and calcium metabolism, VDR ligands are potential therapeutic agents in the treatment of immune disorders, microbial infections, and malignancies. Hypercalcemia, the major adverse effect of vitamin D3 derivatives, limits their clinical application. The secondary bile acid lithocholic acid (LCA) is an additional physiological ligand for VDR, and its synthetic derivative, LCA acetate, is a potent VDR agonist. In this study, we found that an additional derivative, LCA propionate, is a more selective VDR activator than LCA acetate. LCA acetate and LCA propionate induced the expression of the calcium channel transient receptor potential vanilloid type 6 (TRPV6) as effectively as that of 1{alpha},25-dihydroxyvitamin D3 24-hydroxylase (CYP24A1), whereas 1,25(OH)2D3 was more effective on TRPV6 than on CYP24A1 in intestinal cells. In vivo experiments showed that LCA acetate and LCA propionate effectively induced tissue VDR activation without causing hypercalcemia. These bile acid derivatives have the ability to function as selective VDR modulators.

Supplementary key words nuclear receptor • intestine • leukemia • calcium

Abbreviations: AF2, activation function 2; CAMP, cathelicidin antimicrobial peptide; CYP24A1, 1{alpha},25-dihydroxyvitamin D3 24-hydroxylase; FXR, farnesoid X receptor; GPBAR1, G protein-coupled bile acid receptor 1; LCA, lithocholic acid; NBT, nitroblue tetrazolium; 1{alpha}(OH)D3, 1{alpha}-hydroxyvitamin D3; 1,25(OH)2D3, 1{alpha},25-dihydroxyvitamin D3; PXR, pregnane X receptor; RXR, retinoid X receptor; TRPV6, transient receptor potential vanilloid type 6; VDR, vitamin D receptor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
A. N. Bukiya, J. McMillan, A. L. Parrill, and A. M. Dopico
Structural determinants of monohydroxylated bile acids to activate {beta}1 subunit-containing BK channels
J. Lipid Res., November 1, 2008; 49(11): 2441 - 2451.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.